B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SMN1

MOLECULAR TARGET

survival of motor neuron 1, telomeric

UniProt: Q16637NCBI Gene: 66064 compounds

SMN1 (survival of motor neuron 1, telomeric) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SMN1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1branaplam1.795
2Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of1.614
3Niclosamide0.691
4trichostatic acid [Supplementary Concept] related to trichostatin0.691

About SMN1 as a Drug Target

SMN1 (survival of motor neuron 1, telomeric) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented SMN1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SMN1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.